Sonoma Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 235.7%.

Top 21 shareholders own 2.61% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
0.65%	Bruce Thornton	100,825	€16.8k	0%	no data
0.64%	Amy Trombly	100,000	€16.7k	0%	no data
0.3%	Susquehanna International Group, LLP, Asset Management Arm	46,052	€7.7k	0%	no data
0.23%	Geode Capital Management, LLC	35,780	€6.0k	0%	no data
0.2%	Jerome Dvonch	31,009	€5.2k	0%	no data
0.16%	State Street Global Advisors, Inc.	24,315	€4.1k	0%	no data
0.11%	XTX Holdings Limited, Asset Management Arm	16,463	€2.7k	0%	no data
0.086%	Two Sigma Securities, LLC, Asset Management Arm	13,473	€2.2k	0%	no data
0.083%	Millennium Management LLC	13,016	€2.2k	-59.2%	no data
0.077%	Tower Research Capital LLC	11,980	€2.0k	25.9%	no data
0.037%	Jay Birnbaum	5,739	€958.1	0%	no data
0.035%	John McLaughlin	5,414	€903.9	0%	no data
0.015%	BlackRock, Inc.	2,266	€378.3	0%	no data
0.0032%	U.S. Bancorp Asset Management, Inc.	500	€83.4	0%	no data
0.00078%	Wells Fargo & Company, Private Banking and Investment Banking Arm	122	€20.3	16.2%	no data
0.00066%	UBS Asset Management AG	103	€17.2	-98.8%	no data
0.00055%	Morgan Stanley, Investment Banking and Brokerage Investments	86	€14.3	0%	no data
0.00042%	Allworth Financial, L.P.	65	€10.9	0%	no data
0.00028%	Bank of America Corporation, Asset Management Arm	44	€7.3	0%	no data
0.00004%	Carson Wealth Management Group	6	€1.0	0%	no data
0.00001%	HBC Financial Services, PLLC	2	€0.3	0%	no data